Literature DB >> 8995349

Therapy approaches for lymphedema.

P S Mortimer1.   

Abstract

Lymphedema, regardless of etiology, is essentially incurable but different therapy approaches exist which serve to contain swelling. The objectives of treatment are to reduce swelling, restore shape, and prevent inflammatory episodes, eg, recurrent cellulitis. There are essentially three main approaches to lymphedema treatment: physical therapy, drug therapy, and surgery. Any edema arises from an imbalance between capillary filtration and lymph drainage. The principle of physical therapy is to a) reduce excessive capillary filtration and b) improve drainage of interstitial fluid and macromolecules from congested regions to normally draining lymph node sites. This is achieved through a combination of compression, exercise, and if possible, massage. Control of recurrent inflammatory episodes can only be achieved through diabetic type skin care, a reduction in swelling, and if necessary, prophylactic antibiotics. Drug therapy comprises diuretics or the coumarin/flavonoid group of drugs. The use of diuretics for pure lymphedema is physiologically unsound but may be of use in edema of mixed origin and in palliative (cancer) circumstances. Coumarin/flavonoids have been shown to reduce swelling in all types of lymphedema. Surgery is indicated at an early stage for facial swelling, where vision is compromised, or genital lymphedema, where genitourinary function is affected. Otherwise, reducing operations should only be performed when alternative therapy has failed. Microsurgery for certain forms of lymphedema continues to be evaluated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995349     DOI: 10.1177/000331979704800114

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

1.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.

Authors:  Joseph M Rutkowski; Monica Moya; Jimmy Johannes; Jeremy Goldman; Melody A Swartz
Journal:  Microvasc Res       Date:  2006-07-28       Impact factor: 3.514

2.  Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models.

Authors:  Heungman Jun; Ji Yoon Lee; Ji Hun Kim; Minsu Noh; Tae-Won Kwon; Yong-Pil Cho; Young-Sup Yoon
Journal:  Ann Vasc Surg       Date:  2017-05-04       Impact factor: 1.466

3.  Return of lymphatic function after flap transfer for acute lymphedema.

Authors:  S A Slavin; A D Van den Abbeele; A Losken; M A Swartz; R K Jain
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

4.  Increasing public and provider knowledge of lymphedema: evaluation of the lymphedema roadshow.

Authors:  Maria Mathews; Greg Bursey; Amanda Park; Pamela Hodgson; Pat West; Jon Church
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

5.  The Effects of PNF Techniques on Lymphoma in the Upper Limbs.

Authors:  Okchul Hwang; Kyungjin Ha; Seungjun Choi
Journal:  J Phys Ther Sci       Date:  2013-08-20

6.  Nursing intervention in women who developed lymphedema after undergoing a modified radical mastectomy: a pre-experimental study.

Authors:  Gloria Daniela de la Borbolla Martínez; Martha Elena Huitzache Martínez; Nicolás Padilla Raygoza
Journal:  Ecancermedicalscience       Date:  2018-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.